REVB (Revelation Biosciences) Forvard P/E multiplikatori
Revelation Biosciences klinik sinovlarning muvaffaqiyatsizligi va kapital yetishmovchiligi xatarlarini minimallashtirish uchun ma'lumotlar tahlili uchun dasturiy robotlarni joriy qilmoqda. Kompaniyaning kutilayotgan P/E koeffitsiyenti tarixi ushbu jarayonni vizuallashtiradi, bunda 0.00 eng so'nggi metrika ko'rsatkichini ifodalaydi. O'sish potentsiali davlat sug'urta dasturlari orqali buyrak kasalliklari va respirator viruslar bilan kasallangan bemorlar uchun immunomodulyatorlar yetkazib berishga asoslangan.
Revelation Biosciences kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- biznesning bozor baholash ko'rsatkichlari:
- balans kapitallashuvi haqida ma'lumot:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Revelation Biosciences|REVB - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Revelation Bio|REVB - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar Revelation Biosciences Inc|REVB - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Revelation Biosciences|Tezkor likvidlik koeffitsiyenti revbiosciences.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
REVB - Kompaniyaning sof daromadi|Kelajakdagi foyda Revelation Biosciences|REVB - Narxning foydaga nisbati|Forvard P/E multiplikatori Revelation Biosciences Inc|REVB - O‘sish sur’atiga tuzatilgan narx-foyda|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Revelation Biosciences Corp|REVB - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) Revelation Biosciences|REVB - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi revbiosciences.com|REVB - Joriy yil uchun bitta aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Revelation Biosciences
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning jamlanma tahliliyoti:revbiosciences.com
Barqaror aktivlarning professional tanlovi bozor kapitalizatsiyasini prognoz qilingan sof foyda bilan solishtirishga asoslanadi, bu esa ortiqcha baholanganlikni aniqlash imkonini beradi. Revelation Biosciences (REVB) kompaniyasining forward P/E koeffitsiyentini tahlil qilish orqali investor kompaniyaning kelgusidagi pul oqimlarining qiymatini baholaydi, bu esa immun regulyatsiyasi sohasidagi yuqori biologik xatarlar va intensiv R&D pipeline xarajatlarini hisobga olgan holda juda muhimdir.
Revelation Biosciences (REVB) raqobatchilari
Prognoz qilingan narxning foydaga nisbati ARGX (Argenx)|BNTX (BioNTech Group) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ABVX (Abivax SA)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati admabiologics.com (ADMA)|PTGX - Kelajakdagi narxning foydaga nisbati|Immunovant Inc (IMVT) - Prognoz qilingan narxning foydaga nisbati|Kiniksa Corp (KNSA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Grifols, S.A.|Prognoz qilingan narxning foydaga nisbati ADPT|Forvard P/E multiplikatori celldex.com|Kelajakdagi narxning foydaga nisbati Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori VERA (veratx.com)|Dianthus Pharma (DNTH) - Prognoz qilingan narx-foyda nisbati|PHVS - Kelajakdagi narxning foydaga nisbati|ABCL - Forvard P/E multiplikatori|Tourmaline (TRML) - Kelajakdagi narxning foydaga nisbati|Precigen - Kelajakdagi narx-foyda multiplikatori|PHAR (Pharming Group NV) - Forvard P/E multiplikatori|Forvard P/E multiplikatori Nektar Therapeutics|Kelajakdagi narxning foydaga nisbati Upstream Bio Inc (UPB)|Forvard P/E multiplikatori zenasbio.com (ZBIO)|Kelajakdagi narxning foydaga nisbati Immunome Corp IMNM|Forvard P/E multiplikatori Gossamer Bio Inc GOSS|KALV - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Prognoz qilingan narxning foydaga nisbati|Savara Inc. - Kelajakdagi narx-foyda multiplikatori|RIGL (Rigel Pharmaceuticals, Inc.) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati ANAB|Forvard P/E multiplikatori ATXS|ENGN - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RAPT (rapt.com)|Kapitalizatsiyaning kelajakdagi foydaga nisbati JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Kyverna Therapeutics Inc.|TLSA: Forvard P/E multiplikatori|CABA - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|VTYX (ventyxbio.com) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Theratechnologies Inc. THTX|Prognoz qilingan narxning foydaga nisbati AVTX (avalotx.com)|Prognoz qilingan narxning foydaga nisbati Eledon Pharmaceuticals, Inc. ELDN|Kelajakdagi narxning foydaga nisbati Agenus, Inc AGEN|Climb Bio Inc - Kelajakdagi narxning foydaga nisbati|Zura Bio Limited - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati aTyr Pharma, Inc. ATYR|ADAG: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati IMA (ImageneBio)|Prognoz qilingan narxning foydaga nisbati STTK|EQ: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Connect Pharma (CNTB)|Forvard P/E multiplikatori Immunic Therapeutics (IMUX)|Forvard P/E multiplikatori ATRA (Atara Biotherapeutics)|Kelajakdagi narx-foyda multiplikatori IFRX|XFOR (X4 Pharma) - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narx-foyda multiplikatori ACET (adicetbio.com)|CELU: Forvard P/E multiplikatori|inmunebio.com (INMB) - Forvard P/E multiplikatori|BRNS (Barinthus Biotherapeutics PLC) - Forvard P/E multiplikatori|KZR: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Enlivex Therapeutics Ltd ENLV|QTTB - Prognoz qilingan narxning foydaga nisbati|geovax.com - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori EDSA (Edesa Biotech Inc)|IBIO: Forvard P/E multiplikatori|Carisma Tx (CARM) - Forvard P/E multiplikatori|XTLB (XTL Biopharmaceuticals) - Forvard P/E multiplikatori|BOLT: Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati HCWB (HCW Biologics, Inc.)|Forvard P/E multiplikatori Aptevo (APVO)|Forvard P/E multiplikatori AIM (aimimmuno.com)|Forvard P/E multiplikatori Aditxt Corp ADTX|GRI: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori XRTX (xortx.com)|Vyome Holdings Inc. (HIND) - Kelajakdagi narxning foydaga nisbati|Indaptus Therapeutics, Inc. - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Scinai|Prognoz qilingan narx-foyda nisbati CalciMedica, Inc. CALI|Kelajakdagi narxning foydaga nisbati Affimed NV (AFMD)|Forvard P/E multiplikatori Allakos Inc (ALLK)|Kelajakdagi narxning foydaga nisbati hookipapharma.com HOOK|Forvard P/E multiplikatori IGM Biosciences, Inc. IGMS|iTeos Pharma - Forvard P/E multiplikatori|OCEA - Forvard P/E multiplikatori|TCBP: Forvard P/E multiplikatori|Third Harmonic Bio - Kelajakdagi narx-foyda multiplikatori
